ArticleLeukemia & lymphoma2022

Making the case for the case report - informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients.

Nechama J Lipton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.